The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...
We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.
Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...
which started with the Masimo’s claim that its patents had been infringed by the Apple Watch’s pulse-oximetry feature, which allows Watch owners to measure their blood oxygen levels.
A Delaware jury has determined Masimo’s early smartwatches violated Apple’s design patents, adding momentum to their ongoing IP battle. A Delaware federal jury has ruled that early versions of ...
Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S ...
Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S ...
Masimo Corp., an Irvine-based medical device maker trying to broaden to the consumer market, claimed victory over Apple Inc. after a jury trial concluded today in Delaware. “The jury found that Masimo ...
(CNN) — Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that ...
The oximeter placed on his fingertip registered well above the 88 percent blood oxygen saturation level that signals an urgent risk of organ failure and death.
Meanwhile, it secretly packs a medical-grade ECG monitor, a pulse oximeter, and accurate 24/7 heart rate monitoring. While you sleep, the watch automatically tracks blood oxygen levels and uses ...